Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05632055

miRNA (microRNA) and FGF21 (Fibroblast Growth Factor-21) Profile in First Trimester and Gestational Diabetes Prediction

Sponsor: Chiang Mai University

View on ClinicalTrials.gov

Summary

The goal of this observational study is to compare miRNA and FGF21 in pregnancy with and without GDM (Gestational Diabetes) The main question it aims to answer that miRNA and FGF21 are different between two groups. Participants will be retrieved blood sample during first trimester and undergone 100 gm OGTT (oral glucose challenge test) during 24-28 weeks of gestation.

Official title: miRNA and FGF21 Profile in First Trimester and Efficacy of Gestational Diabetes Prediction and Pregnancy Outcomes

Key Details

Gender

FEMALE

Age Range

Any - 45 Years

Study Type

OBSERVATIONAL

Enrollment

160

Start Date

2000-08-26

Completion Date

2026-03-17

Last Updated

2026-03-18

Healthy Volunteers

Yes

Interventions

OTHER

blood draw

Blood test for miRNA and FGF21. However, the laboratory result is not reported and not involved in management

Locations (1)

Maharaj Nakorn ChiangMai Hospital

Chiang Mai, ChiangMai, Thailand